ask="N/A"
ask_size="N/A"
average_daily_volume="1024250"
bid="N/A"
bid_size="N/A"
book_value="4.05"
change="-2.39"
change_from_200_day_moving_average="-4.54"
change_from_50_day_moving_average="-0.78"
change_from_52_week_high="-12.54"
change_From_52_week_low="11.36"
change_in_percent="-5.31%"
close="42.61"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85928000"
high="45.89"
high_52_weeks="55.15"
last_trade_date="1/10/2017"
last_trade_price="42.61"
last_trade_size="99027"
last_trade_time="4:00pm"
low="42.48"
low_52_weeks="31.25"
market_capitalization="3.70B"
moving_average_200_day="47.15"
moving_average_50_day="43.39"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.00"
open="45.25"
pe_ratio="N/A"
peg_ratio="0.72"
percent_change_from_200_day_moving_average="-9.64%"
percent_change_from_50_day_moving_average="-1.80%"
percent_change_from_52_week_high="-22.74%"
percent_change_from_52_week_low="+36.35%"
previous_close="45.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.12"
price_per_sales="260.61"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.97"
stock_exchange="NMS"
symbol="NBIX"
volume="1667000"
weeks_range_52="31.25 - 55.15"
